These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23266555)

  • 1. ORAI3 silencing alters cell proliferation and cell cycle progression via c-myc pathway in breast cancer cells.
    Faouzi M; Kischel P; Hague F; Ahidouch A; Benzerdjeb N; Sevestre H; Penner R; Ouadid-Ahidouch H
    Biochim Biophys Acta; 2013 Mar; 1833(3):752-60. PubMed ID: 23266555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of Orai3 arrests cell-cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells.
    Faouzi M; Hague F; Potier M; Ahidouch A; Sevestre H; Ouadid-Ahidouch H
    J Cell Physiol; 2011 Feb; 226(2):542-51. PubMed ID: 20683915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orai3 calcium channel and resistance to chemotherapy in breast cancer cells: the p53 connection.
    Hasna J; Hague F; Rodat-Despoix L; Geerts D; Leroy C; Tulasne D; Ouadid-Ahidouch H; Kischel P
    Cell Death Differ; 2018 Mar; 25(4):693-707. PubMed ID: 29323264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orai3 constitutes a native store-operated calcium entry that regulates non small cell lung adenocarcinoma cell proliferation.
    Ay AS; Benzerdjeb N; Sevestre H; Ahidouch A; Ouadid-Ahidouch H
    PLoS One; 2013; 8(9):e72889. PubMed ID: 24058448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest.
    Wang X; Li N; Li H; Liu B; Qiu J; Chen T; Cao X
    Clin Cancer Res; 2005 Oct; 11(20):7545-53. PubMed ID: 16243830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ORAI3 silencing alters cell proliferation and promotes mitotic catastrophe and apoptosis in pancreatic adenocarcinoma.
    Dubois C; Kondratska K; Kondratskyi A; Morabito A; Mesilmany L; Farfariello V; Toillon RA; Ziental Gelus N; Laurenge E; Vanden Abeele F; Lemonnier L; Prevarskaya N
    Biochim Biophys Acta Mol Cell Res; 2021 Jun; 1868(7):119023. PubMed ID: 33798603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of proliferation in MCF-7 breast cancer cells by plasmid-based siRNA targeting to oncogene c-myc].
    Zhou CH; Peng XD; Wu J; Zhang P; Zhao ZR; Wei DP; Zhang CJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):373-7. PubMed ID: 18575318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BEX2 regulates mitochondrial apoptosis and G1 cell cycle in breast cancer.
    Naderi A; Liu J; Bennett IC
    Int J Cancer; 2010 Apr; 126(7):1596-610. PubMed ID: 19711341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
    Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation.
    Ding Z; Liu X; Liu Y; Zhang J; Huang X; Yang X; Yao L; Cui G; Wang D
    Mol Carcinog; 2015 May; 54(5):405-15. PubMed ID: 24347226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing the Metallothionein-2A gene inhibits cell cycle progression from G1- to S-phase involving ATM and cdc25A signaling in breast cancer cells.
    Lim D; Jocelyn KM; Yip GW; Bay BH
    Cancer Lett; 2009 Apr; 276(1):109-17. PubMed ID: 19062161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
    Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
    Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.
    Ni HJ; Chang YN; Kao PH; Chai SP; Hsieh YH; Wang DH; Fong JC
    Biochim Biophys Acta; 2012 Dec; 1820(12):1893-900. PubMed ID: 22906975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
    Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
    Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of proto-oncogene Orai3 by miR18a/b and miR34a.
    Vashisht A; Tanwar J; Motiani RK
    Cell Calcium; 2018 Nov; 75():101-111. PubMed ID: 30216788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.
    Mawson A; Lai A; Carroll JS; Sergio CM; Mitchell CJ; Sarcevic B
    Mol Cell Endocrinol; 2005 Jan; 229(1-2):161-73. PubMed ID: 15607540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
    Pannem RR; Dorn C; Ahlqvist K; Bosserhoff AK; Hellerbrand C; Massoumi R
    Carcinogenesis; 2014 Feb; 35(2):461-8. PubMed ID: 24104553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells.
    Xu J; Chen Y; Huo D; Khramtsov A; Khramtsova G; Zhang C; Goss KH; Olopade OI
    Mol Carcinog; 2016 May; 55(5):431-9. PubMed ID: 25663530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A feedback loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast cancer.
    Naderi A; Liu J; Francis GD
    Int J Cancer; 2012 Jan; 130(1):71-82. PubMed ID: 21384344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.